Biostar Pharmaceuticals’ CEO to Join World Leaders at the APEC 2011 CEO Summit on November 11 – 12, 2011 in Hawaii
XIANYANG, China, Nov. 7, 2011 /PRNewswire-Asia-FirstCall/ — Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) (“Biostar” or “the Company”), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its Chairman and Chief Executive Officer, Mr. Ronghua Wang, will attend the Asia-Pacific Economic Cooperation (APEC) 2011 CEO Summit, which will take place from November 11 ? 12, 2011 in Honolulu, Hawaii.
Additionally, on November 10, 2011, Mr. Wang will present at the Asia-Pacific Business Symposium, a two-day series of workshops, held in conjunction with APEC 2011 CEO Summit. During his speech, Mr. Wang will focus on the importance of the cooperation between United States and China on trade and investment and discuss his experience as a CEO of a U.S. listed company.
The Asia-Pacific Business Symposium is sponsored by the Pacific Basin Economic Council, the East-West Center and supported by the APEC Business Advisory Council. The Symposium will be a gathering of business leaders from around the Asia-Pacific Region, including many attendees of APEC 2011 CEO Summit, to discuss various topics related to trade, sustainability, and other issues of importance to the region.
The APEC CEO Summit is the Asia-Pacific’s premier business event, drawing thousands of economic and business leaders from around the region and beyond. The APEC CEO Summit provides unparalleled opportunity for business executives to dialogue with global leaders and ministers of foreign affairs and trade, network with CEOs from hundreds of top Asia-Pacific companies, and to forge connections with economic thought leaders from around the region and the world. Barack Obama, President of the United States, along with Hu Jintao, President of China, Dmitry Medvedev, President of Russia, and Susilo Bambang Yudhoyono, President of Indonesia, are among world leaders expected at the APEC CEO 2011 Summit.
Mr. Wang commented, “I am honored to again be invited to be part of the Chinese delegation and represent our nation’s pharmaceutical industry in both these important economic events. On November 12th, at the APEC CEO 2011 Summit, the Chinese delegation headed by President Hu Jintao will discuss health trends in Asia, the region’s aging population and how changes in diet and exercise have resulted in an increase in chronic diseases in Asian economies, posing a rising burden on business and society. I look forward to discussing these issues with world and business leaders and sharing ideas and possible solutions that could reverse these trends, and exploring policy choices weighing both opportunities and obstacles that lie ahead of us.”
About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company’s most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (“OTC”) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit: http://www.biostarpharmaceuticals.com.
For more information contact:
Biostar Pharmaceuticals, Inc. The Equity Group, Inc. Zack Pan, CFO Lena Cati Tel: 405-996-8829 Tel: 212 836-9611 Email: zpan@aoxing- group.com Email: firstname.lastname@example.org
SOURCE Biostar Pharmaceuticals, Inc.